Andy Hurd is a Partner at Cressey & Company responsible for identifying, consummating, and monitoring new investment partnerships as well as developing relationships with talented healthcare executives.

Andy joined Cressey in 2018 with 30 years of experience in healthcare and healthcare IT leadership, with expertise in product and go-to-market innovation as well as building meaningful strategic partnerships.

Andy has served as CEO of three successful healthcare technology businesses. Andy’s experience includes Chairman and CEO of MedeAnalytics, a data and analytics provider to providers and health plans, CEO of Epocrates (NASDAQ: EPOC), a mobile clinical application used by half the physicians in the US, and Chairman and CEO of Carefx, which enabled clinical interoperability of data and applications to providers.

Andy holds a bachelor’s degree in Business Administration from Northern Arizona University and serves on the Innovations Advisory Board of Mass General Brigham.